Delivery Order SPE2DB20D2104-SPE2DB24FT53L
Award Date 4/9/24
Potential Completion Date 4/10/24
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Colestipol HCL 1 GM tablets. The contract, valued at $1,020.64, was awarded by the Defense Logistics Agency (DLA) on June 6, 2024, with a completion date of June 7, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,657.00 firm fixed-price contract is for the supply of 4,565,214,052 units of Colestipol HCL 1 GM Tablets. The contract has an ultimate completion date of July 22, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded multiple indefinite delivery contracts (IDCs) with DLA and other federal agencies, including a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,106.98, is for the delivery of Colestipol HCL 1 GM Tablets in quantities of 120s. The contract has an ultimate completion date of March 18, 2025 and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,568.93 to AmerisourceBergen Drug Corp for the supply of Colestipol HCL 1 GM tablets (120-count package) on January 8, 2026, with completion scheduled for January 9, 2026. This is a firm fixed-price contract with no set-aside designation, awarded on a fully competitive basis. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order was...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,114.21 Firm Fixed Price delivery order is for the supply of Colestipol HCL 1 GM Tablets in quantities of 120 tablets. The award has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award is a delivery order with a firm fixed price ceiling value of $1,054.44, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the supply of Colestipol HCl 1 GM Tablets in 120-count packages, with a period of performance through June 12, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Colestipol HCL 1 GM Tablets, with a ceiling value of $1,157.80 and a performance period ending on May 20, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, with the ID SPE2DX15D2101|SPE2DX24F48LB, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,262.06 firm fixed-price delivery order is for the supply of Colestipol HCL 1 GM Tablets to support federal healthcare programs. The award has an ultimate completion date of November 20, 2023 and was made on November 17, 2023. This contract is not designated as a set-aside....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Colestipol Hydrochloride 1 gram tablets, a medication used to treat high cholesterol. The contract has a ceiling value of $2,250.86 and is a firm fixed-price contract with an ultimate completion date of April 22, 2025. The contract is not designated as a set-aside and was awarded on April...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,462.98 contract is for the delivery of 120 count tablets of Colestipol HCl 1 GM, a medication used to treat high cholesterol. The contract has a completion date of May 9, 2023 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen holds a larger...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT53LDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,220,957 units of Colestipol HCl 1 gram tablets. The $4,005.65 firm fixed price delivery order has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was not set aside for any particular business category.
Generated 7/9/24, 1:25 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 4/9/24 |